Bruno Villa
May 2, 2020
MEDEPHARM is pleased to announce the release of Alix, an innovative integrated worldwide R&D platform for demanding formulation scientists.
Alix software enables the ultra-compact STYL’One Nano laboratory tabletting R&D press to become a complete research environment that can move the researcher from a powder sample to a full analytical chart in just a few minutes.
9 June 2020
MEDELPHARM is pleased to announce the release of Alix, an innovative integrated worldwide R&D platform for demanding formulation scientists.
Alix software enables the ultra-compact STYL’One Nano laboratory tabletting R&D press to become a complete research environment that can move the researcher from a powder sample to a full analytical chart in just a few minutes.
Alix features
Alix is an integrated software platform, designed for formulation and R&D scientists in solid dosage environments. It supports different compaction profiles, tabletting applications and incorporates a series of advanced features and functions:
Alix benefits
Alix equips STYL’One Nano users with the ability to orchestrate lab instruments and share data for a more efficient experimental and research environment resulting in faster, better results. It delivers a series of specific benefits:
With Alix and STYL’One Nano working in combination, MEDELPHARM has provided researchers with the “Technology of the future under your gloves”, giving access to all data anywhere and orchestrating all laboratory tabletting instruments.
Alix allows research teams to consolidate data from different instruments to generate smart analytics and perform development studies faster and more reliably.
Alix will be rolled out to other MEDELPHARM platforms, such as STYL’One Evolution, in the future.